Literature DB >> 31347695

Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation.

Amparo Ruiz-Sauri1, Jorge M Orduña-Valls2,3, Arantxa Blasco-Serra4, Carlos Tornero-Tornero2,3, David L Cedeño5,6,7, Daniel Bejarano-Quisoboni2, Alfonso A Valverde-Navarro4, Ramsin Benyamin3,5,6,7, Ricardo Vallejo3,5,6,7.   

Abstract

Spinal cord stimulation (SCS) applied between T8 and T11 segments has been shown to be effective for the treatment of chronic pain of the lower back and limbs. However, the mechanism of the analgesic effect at these medullary levels remains unclear. Numerous studies relate glial cells with development and maintenance of chronic neuropathic pain. Glial cells are electrically excitable, which makes them a potential therapeutic target using SCS. The aim of this study is to report glia to neuron ratio in thoracic segments relevant to SCS, as well as to characterize the glia cell population at these levels. Dissections from gray and white matter of posterior spinal cord segments (T8, T9, intersection T9/T10, T10 and T11) were obtained from 11 human cadavers for histological analyses. Neuronal bodies and glial cells (microglia, astrocytes and oligodendrocytes) were immunostained, microphotographed and counted using image analysis software. Statistical analyses were carried out to establish significant differences of neuronal and glial populations among the selected segments, between the glial cells in a segment, and glial cells in white and gray matter. Results show that glia to neuron ratio in the posterior gray matter of the human spinal cord within the T8-T11 vertebral region is in the range 11 : 1 to 13 : 1, although not significantly different among vertebral segments. Glia cells are more abundant in gray matter than in white matter, whereas astrocytes and oligodendrocytes are more abundant than microglia (40 : 40 : 20). Interestingly, the population of oligodendrocytes in the T9/T10 intersection is significantly larger than in any other segment. In conclusion, glial cells are the predominant bodies in the posterior gray and white matter of the T8-T11 segments of the human spinal cord. Given the crucial role of glial cells in the development and maintenance of neuropathic pain, and their electrophysiological characteristics, anatomical determination of the ratio of different cell populations in spinal segments commonly exposed to SCS is fundamental to understand fully the biological effects observed with this therapy.
© 2019 Anatomical Society.

Entities:  

Keywords:  anatomy; glial cells; neurons; spinal cord

Year:  2019        PMID: 31347695     DOI: 10.1111/joa.13061

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  8 in total

1.  Spinal Cord Stimulation Alleviates Neuropathic Pain by Attenuating Microglial Activation via Reducing Colony-Stimulating Factor 1 Levels in the Spinal Cord in a Rat Model of Chronic Constriction Injury.

Authors:  Cong Sun; Xueshu Tao; Chengfu Wan; Xiaojiao Zhang; Mengnan Zhao; Miao Xu; Pinying Wang; Yan Liu; Chenglong Wang; Qi Xi; Tao Song
Journal:  Anesth Analg       Date:  2022-04-04       Impact factor: 6.627

Review 2.  Dorsal Root Ganglion Stimulation for Chronic Pain: Hypothesized Mechanisms of Action.

Authors:  Robert D Graham; Vishwanath Sankarasubramanian; Scott F Lempka
Journal:  J Pain       Date:  2021-08-20       Impact factor: 5.820

3.  Electrical Stimulation of C6 Glia-Precursor Cells In Vitro Differentially Modulates Gene Expression Related to Chronic Pain Pathways.

Authors:  Ricardo Vallejo; David C Platt; Jonathan A Rink; Marjorie A Jones; Courtney A Kelley; Ashim Gupta; Cynthia L Cass; Kirk Eichenberg; Alejandro Vallejo; William J Smith; Ramsin Benyamin; David L Cedeño
Journal:  Brain Sci       Date:  2019-10-31

Review 4.  Modulation of Glia-Mediated Processes by Spinal Cord Stimulation in Animal Models of Neuropathic Pain.

Authors:  David L Cedeño; Courtney A Kelley; Krishnan Chakravarthy; Ricardo Vallejo
Journal:  Front Pain Res (Lausanne)       Date:  2021-07-14

Review 5.  Emerging Evidence for Intrathecal Management of Neuropathic Pain Following Spinal Cord Injury.

Authors:  Jay Karri; James Doan; Christian Vangeison; Marissa Catalanotto; Ameet S Nagpal; Sheng Li
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-28

6.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

7.  Modulation of neuroglial interactions using differential target multiplexed spinal cord stimulation in an animal model of neuropathic pain.

Authors:  Ricardo Vallejo; Courtney A Kelley; Ashim Gupta; William J Smith; Alejandro Vallejo; David L Cedeño
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

Review 8.  Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome.

Authors:  Marco Echeverria-Villalobos; Justin Mitchell; Juan Fiorda-Diaz; Tristan Weaver
Journal:  J Pain Res       Date:  2021-07-30       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.